
A comprehensive guide for pharmaceutical marketing teams to plan, build, and optimize a custom HCP engagement portal to boost physician engagement through educational content, interactive tools, and personalized experiences.
A comprehensive guide for pharmaceutical marketing teams to plan, build, and optimize a custom HCP engagement portal to boost physician engagement through educational content, interactive tools, and personalized experiences.
A comprehensive guide for technical administrators on configuring user-level security in Veeva Vault, covering security profiles, permission sets, roles, and best practices for compliance.
A comprehensive guide to modern data warehousing solutions for life sciences organizations, covering cloud vs. on-premise strategies, technology stacks, compliance requirements, and scalable approaches for organizations of all sizes.
Practical strategies to boost Veeva CRM adoption among sales reps and MSLs, addressing common challenges like poor user experience, lack of training, and resistance to change.
A comprehensive overview of Customer Relationship Management (CRM) platforms tailored for biotech companies, comparing various solutions and their features for compliance, sales, and customer relationship management in the life sciences sector.
A comprehensive guide for pharmaceutical marketers on planning and executing market access pull-through campaigns using Veeva CRM and Vault, from stakeholder targeting to field execution.
A comprehensive comparison of CRM requirements between pharmaceutical companies and other life sciences organizations, examining key differences in sales, marketing, compliance, and patient engagement approaches.
A comprehensive comparison of three approaches to adapting large language models for pharmaceutical applications: fine-tuning, distillation, and prompt engineering, with technical details and real-world examples.
A comprehensive analysis of Veeva's decision to end its partnership with Salesforce, exploring the strategic implications, timeline of events, and impact on life sciences companies facing this major industry transition.